Back to Search Start Over

CRISPR-AMRtracker: A novel toolkit to monitor the antimicrobial resistance gene transfer in fecal microbiota.

Authors :
Li G
Long TF
Zhou SY
Xia LJ
Gao A
Wan L
Diao XY
He YZ
Sun RY
Yang JT
Tang SQ
Ren H
Fang LX
Liao XP
Liu YH
Chen L
Sun J
Source :
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2024 Nov; Vol. 77, pp. 101142. Date of Electronic Publication: 2024 Aug 24.
Publication Year :
2024

Abstract

The spread of antibiotic resistance genes (ARGs), particularly those carried on plasmids, poses a major risk to global health. However, the extent and frequency of ARGs transfer in microbial communities among human, animal, and environmental sectors is not well understood due to a lack of effective tracking tools. We have developed a novel fluorescent tracing tool, CRISPR-AMRtracker, to study ARG transfer. It combines CRISPR/Cas9 fluorescence tagging, fluorescence-activated cell sorting, 16S rRNA gene sequencing, and microbial community analysis. CRISPR-AMRtracker integrates a fluorescent tag immediately downstream of ARGs, enabling the tracking of ARG transfer without compromising the host cell's antibiotic susceptibility, fitness, conjugation, and transposition. Notably, our experiments demonstrate that sfGFP-tagged plasmid-borne mcr-1 can transfer across diverse bacterial species within fecal samples. This innovative approach holds the potential to illuminate the dynamics of ARG dissemination and provide valuable insights to shape effective strategies in mitigating the escalating threat of antibiotic resistance.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1532-2084
Volume :
77
Database :
MEDLINE
Journal :
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Publication Type :
Academic Journal
Accession number :
39214042
Full Text :
https://doi.org/10.1016/j.drup.2024.101142